Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 3Recruiting 3Withdrawn 1Suspended 1Completed 1

Sponsor Class

INDUSTRY 3

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Breast 3

Conditions

Breast Neoplasms 3Neoplasm Metastasis 2

Interventions

Cyclophosphamide 390Carboplatin 344Gemcitabine 332pembrolizumab 329Cisplatin 328Paclitaxel 297Radiotherapy 296Docetaxel 286Bevacizumab 253Rituximab 234Capecitabine 223Nivolumab 220Dexamethasone 206Fluorouracil 190fludarabine 177Oxaliplatin 177Pemetrexed 153Doxorubicin 153Irinotecan 148Leucovorin 144Etoposide 144Cytarabine 133Cetuximab 129Bortezomib 129fludarabine phosphate 128Lenalidomide 126Erlotinib Hydrochloride 120Filgrastim 119Temozolomide 113Radiosurgery 113

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Biological Assay × Clear all
NCT00595023 2016-01-12

GeneSearch Breast Lymph Node (BLN) Assay Timing Study

Janssen Diagnostics, LLC

Terminated
233 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis

NCT00595296 2016-01-12

GeneSearchâ„¢ Breast Lymph Node (BLN) Assay Post Approval Study

Janssen Diagnostics, LLC

Terminated
461 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis

NCT00869674 2013-05-30

GeneSearchâ„¢ Breast Lymph Node (BLN) Assay China Registration Study

Johnson & Johnson Medical, China

Phase 3 Terminated
540 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡